Health

China Biologic Reports Financial Results for the Second Quarter of 2020

BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...

2020-08-18 04:30 9338

WuXi Biologics Records Excellent Interim Results

Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million Net Profit Up 62.6% to RMB730.7 Million Profit Attributable to Owners of the Company Up 63.6% Y-o-Y to RMB736.1 Million Adjusted Net Profit Up 40.7% Y-o-Y to RMB734.0 Million Diluted EPS Up 55.9% Y-o-Y to RMB0.53 Adjusted Diluted EPS Up 38.5% Y-o-Y to RMB...

2020-08-18 00:51 2804

Start of bridging pharmacokinetic and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator O304

STOCKHOLM, Aug. 17, 2020 /PRNewswire/ -- In previous Phase I and Phase IIa clinical trials in healthy subjects and in type 2 diabetics, the small molecule AMPK activator compound O304 was administered as a suspension and with limited oral bioavailability. A novel formulation of O304 has now been ...

2020-08-17 22:13 2425

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China

SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...

2020-08-17 20:00 3356

Sirtex Medical announces partnership with Magle Chemoswed

Collaboration grants Sirtex global use of innovative technology to develop novel imaging agent for interventional oncology WOBURN, Massachusetts, Aug. 17, 2020 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced a coll...

2020-08-17 20:00 2245

CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...

2020-08-17 18:00 3404

Great Big Story celebrates the innovative spirit of Singapore's Problem Solvers

HONG KONG, Aug. 17, 2020 /PRNewswire/ -- In its new Problem Solvers  series this month, Great Big Story meets the creators based inSingapore pushing the boundaries of technology and making innovative products with a social impact...

2020-08-17 12:55 3558

First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody

HANGZHOU, China and SHAOXING, China, Aug. 17, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of ASC22, which is a first-in-class, subcutaneously administered PD-L1 antibody. ASC22(Envafolimab) Phase IIa clin...

2020-08-17 08:30 3635

iHerb Announces Major Global Delivery Expansion

PASADENA, California, Aug. 17, 2020 /PRNewswire/ -- Global health and beauty e-commerce leader iHerb is expanding its global availability to 23 additional countries, one of the largest expansions in the company's history. This is in addition to the 165 countries and territories iHerb already serv...

2020-08-17 08:29 3694

China's First Trastuzumab Biosimilar Approved by NMPA

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced onAugust 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). On 27th July, HLX02 (EU bran...

2020-08-17 08:00 3954

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

HYDERABAD, India, Aug. 17, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today announced the inauguration of its new Rese...

2020-08-17 08:00 3549

Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index

SUZHOU, China, and ROCKVILLE, MD., Aug. 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has been s...

2020-08-17 07:30 2850

Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19

SCHLIEREN, Switzerland and VILNIUS, Lithuania, Aug. 15, 2020 /PRNewswire/ -- Swiss biotech companyMemo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx...

2020-08-15 08:36 4516

Lee's Pharm Announced 2020 Interim Results Positive Profit Alert

HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited  ("Lee's Pharm" or the "Group", Stock Code: 950), an integrated research-driven and market-oriented pharmaceutical group inChina, is pleased to announce that it is anticipated that the Group's will record a significant ...

2020-08-14 23:49 10146

China Jo-Jo Drugstores Reports First Quarter 2021 Financial Results

HANGZHOU, China, Aug. 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its fina...

2020-08-14 21:00 7780

China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

HAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2020-08-14 18:30 5806

Dymax Asia Pacific Pte Ltd Receives the Singapore SME 1000 & SME 1000 Award and Winner of D&B Business Eminence Award

TORRINGTON, Conn., Aug. 14, 2020 /PRNewswire/ -- Dymax Corporation , leading manufacturer of rapid light-curing materials and equipment, is pleased to announce that itsSingapore subsidiary, Dymax Asia Pacific Pte Ltd., has received theSingapore 1000 & Singapore SME 1000 award ...

2020-08-14 16:17 4737

Family Mask Supports UNGC Leaders' Summit 2020

HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Family Mask is honoured to be an official supporting organization of United Nations Global Compact Leaders' Summit 2020, where more than 20,000 sustainability champions gathered over 26 hours of continuous virtual programming to address the private sector'...

2020-08-14 15:30 3621

Bushu Pharmaceuticals Announces Major Expansion Program

KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...

2020-08-14 14:00 2287

Sinopharm Tech plans to purchase 337 tons Meltblown Fabric

HONG KONG, August 14, 2020 /PRNewswire/ -- Sinopharm Tech Holdings Limited ("Sinopharm Tech" and its subsidiaries, together, the "Group", stock code: 8156)  is pleased to announce that, as of 13 August, 2020, the subsidiary of the Group has entered into product sales agreements with a branch of Pe...

2020-08-14 09:18 4371
1 ... 651652653654655656657 ... 820